Search - tctmd.com

Displaying 1 - 20 of 69

Sort: Relevancy | Date

December 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

December 2024 Dispatch for the CV Team

December 20, 2024

CVD Risks Vary by Type of Menopausal Hormone Replacement Therapy

News Daily News

CVD Risks Vary by Type of Menopausal Hormone Replacement Therapy

December 04, 2024

Increased CVD Risk Seen Up to 30 Years Before Type 2 Diabetes Diagnosis

News Daily News

Increased CVD Risk Seen Up to 30 Years Before Type 2 Diabetes Diagnosis

November 28, 2024

CMS Proposal Would Expand Medicare, Medicaid Coverage for GLP-1 Drugs

News Daily News

CMS Proposal Would Expand Medicare, Medicaid Coverage for GLP-1 Drugs

November 27, 2024

First-line Catheter Ablation Works for Post-MI VT Suppression: VANISH2

News Conference News AHA 2024

First-line Catheter Ablation Works for Post-MI VT Suppression: VANISH2

November 16, 2024

US Obesity Epidemic Continues to Skyrocket, With No End in Sight

News Conference News AHA 2024

US Obesity Epidemic Continues to Skyrocket, With No End in Sight

Michael O'Riordan

November 15, 2024

After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry

News Conference News TCT 2024

After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry

Yael L. Maxwell

November 05, 2024

Embolic Protection Benefits Varied by Geography in PROTECTED TAVR

News Conference News TCT 2024

Embolic Protection Benefits Varied by Geography in PROTECTED TAVR

October 31, 2024

TCT 102: First-in-Man Experience With the Self-Expandable A-Flux Coronary Sinus Reducer for Treating Symptomatic Ischemic Heart Disease

Presentation TCT 2024

TCT 102: First-in-Man Experience With the Self-Expandable A-Flux Coronary Sinus Reducer for Treating Symptomatic Ischemic Heart Disease

Presenter: Francesco Giannini

October 30, 2024

The Transformation of Diagnosis and Risk Profiling for Ischemic Heart disease: An AI Case Study

Presentation TCT 2024

The Transformation of Diagnosis and Risk Profiling for Ischemic Heart disease: An AI Case Study

Presenter: James Min

October 30, 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

News Conference News TCT 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Michael O'Riordan

October 29, 2024

TCT 250: Temporal Trends in Ischemic Heart Disease-related Mortality in Canada Over the Past 3 Decades

Presentation TCT 2024

TCT 250: Temporal Trends in Ischemic Heart Disease-related Mortality in Canada Over the Past 3 Decades

Presenter: Ahmed Abdulelah

October 29, 2024

Final Results of the Novel Healing-Targeted DES With Synchronized Antiproliferative Drug Delivery to Target Smooth Muscle Cell Proliferation After DES Implantation in Coronary Artery Disease: 5-Year Results of the PIONEER III Trial

Presentation TCT 2024

Final Results of the Novel Healing-Targeted DES With Synchronized Antiproliferative Drug Delivery to Target Smooth Muscle Cell Proliferation After DES Implantation in Coronary Artery Disease: 5-Year Results of the PIONEER III Trial

Presenter: Thomas Sharp

October 28, 2024

October 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

October 2024 Dispatch for the CV Team

October 25, 2024

Age Cutoffs for PFO Closure Deserve a Rethink, Researchers Urge

News Daily News

Age Cutoffs for PFO Closure Deserve a Rethink, Researchers Urge

October 15, 2024

More Trees Means Less CVD, Florida Census Data Suggest

News Daily News

More Trees Means Less CVD, Florida Census Data Suggest

Yael L. Maxwell

October 15, 2024

AHA Statement Outlines Cardiac Contributions to Brain Health

News Daily News

AHA Statement Outlines Cardiac Contributions to Brain Health

October 11, 2024

SCAI Releases Practical, Technical Advice for Primary PCI in STEMI

News Daily News

SCAI Releases Practical, Technical Advice for Primary PCI in STEMI

Michael O'Riordan

October 10, 2024

EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER

News Conference News HFSA 2024

EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER

October 03, 2024

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

News Daily News

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Michael O'Riordan

September 27, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.